Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCZ103-OS in 2nd-line mCRC
NCT01378143Phase 2Completed
- Sponsor
- Oncozyme Pharma
- Start
- Mar 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OCZ103-OS in colorectal cancer (CRC), sponsored by Oncozyme Pharma. Started Mar 2011; status: completed.
02
Drugs
OCZ103-OS
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01378143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01378143.